scholarly journals Postoperative Portal Hypertension Enhances Alloimmune Responses after Living-Donor Liver Transplantation in Patients and in a Mouse Model

2019 ◽  
Vol 203 (5) ◽  
pp. 1392-1403 ◽  
Author(s):  
Shinji Hashimoto ◽  
Takashi Onoe ◽  
Masataka Banshodani ◽  
Kazuhiro Taguchi ◽  
Yuka Tanaka ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Portal Hypertension ◽  
Mouse Model ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Donor Liver ◽  
Donor Liver Transplantation

scholarly journals PORTAL HYPERTENSION INCREASE ANTI-DONOR IMMUNE RESPONSE AFTER LIVING DONOR LIVER TRANSPLANTATION IN PATIENTS AND MOUSE MODEL

2020 ◽  
Vol 104 (S3) ◽  
pp. S495-S496
Author(s):  
Takashi Onoe ◽  
Shinji Hashimoto ◽  
Masataka Banshodani ◽  
Kazuhiro Taguchi ◽  
Yuka Tanaka ◽  
...  
Keyword(s):  
Immune Response ◽  
Liver Transplantation ◽  
Portal Hypertension ◽  
Mouse Model ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Donor Liver ◽  
Donor Liver Transplantation

scholarly journals A Novel Predictor of Posttransplant Portal Hypertension in Adult-To-Adult Living Donor Liver Transplantation

2016 ◽  
Vol 100 (10) ◽  
pp. 2138-2145 ◽  
Author(s):  
Kazuyuki Gyoten ◽  
Shugo Mizuno ◽  
Hiroyuki Kato ◽  
Yasuhiro Murata ◽  
Akihiro Tanemura ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Portal Hypertension ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Donor Liver ◽  
Donor Liver Transplantation

Adult-to-Adult Living-Donor Liver Transplantation

Swiss Surgery ◽  
2003 ◽  
Vol 9 (5) ◽  
pp. 227-236 ◽  
Author(s):  
Majno ◽  
Mentha ◽  
Berney ◽  
Bühler ◽  
Giostra ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Therapeutic Option ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Multidisciplinary Program ◽  
First Case ◽  
Living Donor Transplantation ◽  
The Right

Living donor liver transplantation is a relatively new procedure in which the right side of the liver is harvested in a healthy donor and transplanted into a recipient. After the first case in 1994, over 3000 cases have been done worldwide. This review summarizes the reasons why the procedure is needed, describes its main technical aspects, highlights the boundaries in which it can be done safely, summarizes the current experience worldwide and describes the main points of the program in our unit. We argue that living-donor transplantation is a viable alternative to a long time on the waiting list for several patients, and it can be performed safely and successfully provided that all precautions are undertaken to minimize the risks in the donor and to increase the chances of a good outcome in the recipients. If these prerequisites are met, and within the framework of a structured multidisciplinary program, we believe that living-donor liver transplantation should be funded by health insurances as a recognized therapeutic option.

Sign in / Sign up

Export Citation Format

Share Document